6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
16h ago	Club Offers for Travel Enthusiasts in Germany
17h ago	Montfort Capital Announces Delay in Filing Annual Financial Statements and MD&A, Issuance of Cease Trade Order
Yesterday	TelkomGroup Launches Pukpuk Submarine Cable: The First Digital Bridge Connecting Indonesia and Papua New Guinea
Yesterday	Altura Energy Announces Major Shareholder Increases Position Following Purchase in Open Market
Yesterday	Carrier Connect Data Solutions Inc. Completes Acquisition of Network Connectivity and Delivery Assets from Morewave Communication and Engages Capital Analytica for Marketing Services

About

Corvus Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results

Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors

Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting

Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

Recent Videos

IP Minute February 24, 2026 - Did Celera Genomics just spawn a 2nd billion-dollar drug?

IP Minute February 24, 2026 - Did Celera Genomics just spawn a 2nd billion-dollar drug?

Feb 24, 2026

CRVS STOCK : MAJOR BREAKOUT | CORVUS PHARMACEUTICALS STOCK

CRVS STOCK : MAJOR BREAKOUT | CORVUS PHARMACEUTICALS STOCK

Feb 19, 2026

Targeting ITK: How Corvus Soquelitinib (CPI-818) is Revolutionizing Atopic Dermatitis Treatment

Targeting ITK: How Corvus Soquelitinib (CPI-818) is Revolutionizing Atopic Dermatitis Treatment

Feb 03, 2026

CRVS Stock Surge Explained: Corvus Pharmaceuticals’ Rise & Key Lessons for Investors

CRVS Stock Surge Explained: Corvus Pharmaceuticals’ Rise & Key Lessons for Investors

Jan 28, 2026

Community Chat

Ask AI